BIOMAT Database Logo BIOMAT Database Logo

HLA typing of amniotic cells: the prenatal diagnosis of congenital adrenal hyperplasia (21-OH-deficiency type). 1979

M S Pollack, and D Maurer, and L S Levine, and M I New, and S Pang, and M A Duchon, and R P Owens, and I R Merkatz, and H M Nitowsky, and G Sachs, and B Dupont

UI MeSH Term Description Entries
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000312 Adrenal Hyperplasia, Congenital A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. Congenital Adrenal Hyperplasia,Hyperplasia, Congenital Adrenal,Adrenal Hyperplasias, Congenital,Congenital Adrenal Hyperplasias,Hyperplasias, Congenital Adrenal

Related Publications

M S Pollack, and D Maurer, and L S Levine, and M I New, and S Pang, and M A Duchon, and R P Owens, and I R Merkatz, and H M Nitowsky, and G Sachs, and B Dupont
Prenatal diagnosis of congenital adrenal hyperplasia (21-OH deficiency type) by HLA typing.
January 1981, Prenatal diagnosis,
M S Pollack, and D Maurer, and L S Levine, and M I New, and S Pang, and M A Duchon, and R P Owens, and I R Merkatz, and H M Nitowsky, and G Sachs, and B Dupont
Amniotic 17-alpha hydroxyprogesterone and HLA typing for the prenatal diagnosis of 21-alpha hydroxylase deficiency--congenital adrenal hyperplasia.
January 1980, American journal of medical genetics,
M S Pollack, and D Maurer, and L S Levine, and M I New, and S Pang, and M A Duchon, and R P Owens, and I R Merkatz, and H M Nitowsky, and G Sachs, and B Dupont
HLA typing of amniotic-fluid cells applied to prenatal diagnosis of congenital adrenal hyperplasia.
May 1979, Lancet (London, England),
M S Pollack, and D Maurer, and L S Levine, and M I New, and S Pang, and M A Duchon, and R P Owens, and I R Merkatz, and H M Nitowsky, and G Sachs, and B Dupont
Particular interest of HLA typing for genetic counselling in families with congenital adrenal hyperplasia (21-OH deficiency).
January 1987, Haematologia,
M S Pollack, and D Maurer, and L S Levine, and M I New, and S Pang, and M A Duchon, and R P Owens, and I R Merkatz, and H M Nitowsky, and G Sachs, and B Dupont
[Prenatal detection of congenital adrenal hyperplasia using HLA typing of fetal cells from the amniotic fluid].
January 1986, Lijecnicki vjesnik,
M S Pollack, and D Maurer, and L S Levine, and M I New, and S Pang, and M A Duchon, and R P Owens, and I R Merkatz, and H M Nitowsky, and G Sachs, and B Dupont
Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by amniotic fluid steroid analysis.
April 1982, Prenatal diagnosis,
M S Pollack, and D Maurer, and L S Levine, and M I New, and S Pang, and M A Duchon, and R P Owens, and I R Merkatz, and H M Nitowsky, and G Sachs, and B Dupont
Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
July 1985, The Journal of clinical endocrinology and metabolism,
M S Pollack, and D Maurer, and L S Levine, and M I New, and S Pang, and M A Duchon, and R P Owens, and I R Merkatz, and H M Nitowsky, and G Sachs, and B Dupont
Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
January 1985, Annals of the New York Academy of Sciences,
M S Pollack, and D Maurer, and L S Levine, and M I New, and S Pang, and M A Duchon, and R P Owens, and I R Merkatz, and H M Nitowsky, and G Sachs, and B Dupont
Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) in Croatia.
October 1997, American journal of medical genetics,
M S Pollack, and D Maurer, and L S Levine, and M I New, and S Pang, and M A Duchon, and R P Owens, and I R Merkatz, and H M Nitowsky, and G Sachs, and B Dupont
Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
May 1977, Pediatrics,
Copied contents to your clipboard!